**Author details**

Juan Mieres\* and Alfredo E. Rodríguez Otamendi Hospital, Buenos Aires, Argentina

\*Address all correspondence to: juanmieres@gmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**23**

*Current Status, Perspectives, and Future Directions of Multivessel Disease and Left Main…*

[8] Farooq V, Brugaletta S, Serruys PW, et al. The SYNTAX score and SYNTAXbased clinical risk scores. Seminars in Thoracic and Cardiovascular Surgery.

[9] Rodriguez AE, Fernandez-Pereira C, Mieres J, et al. Modifying angiographic syntax score according to PCI strategy: Lessons learnt from ERACI IV study. Cardiovascular Revascularization Medicine. 2015;**16**(7):418-420

[10] Negreiros de Andrade PJ, de Alencar Araripe Falcão JL, de Alencar Araripe Falcão B, et al. Stent versus coronary artery bypass surgery in multi-vessel and left Main coronary artery disease: A meta-analysis of randomized trials with subgroups evaluation. Arquivos Brasileiros de Cardiologia.

[11] Kobayashi Y, Nam CW, Tonino PA, et al. The prognostic value of residual coronary stenoses after functionally complete revascularization. Journal of the American College of Cardiology.

2011;**23**:99-105

2019;**112**(5):511-523

2016;**67**:1701-1711

1993;**22**:1060-1067

2017;**65**(1):81-90

[12] Rodriguez A, Boullon F, Perez-Balino N, et al. Argentine randomized trial of percutaneous transluminal coronary angioplasty vs coronary artery bypass surgery in multivessel disease (ERACI): In hospital results and 1-year follow-up. Journal of the American College of Cardiology.

[13] Rodriguez AE, Santaera O, Larribau M, et al. Second versus first drug eluting stents in complex lesions subsets: 3 years follow up of ERACI IV study. Minerva Cardioangiologica.

[14] Rodriguez AE, Larribau M, Fernandez-Pereira C, et al. One-year follow-up results from the observational, multicenter, prospective, and controlled

*DOI: http://dx.doi.org/10.5772/intechopen.89419*

[1] Rodriguez AE, Baldi J, Fernández Pereira C, et al. Five-year follow-up of the argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). Journal of the American College of Cardiology.

**References**

2005;**46**(4):582-588

2009;**360**(10):961-972

2015;**372**(13):1204-1212

2015;**386**(10006):1853-1860

2017;**376**(19):1813-1823

2018;**72**(22):2732-2743

[6] Al-Lamee R, Thompson D,

Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): A double-blind, randomised controlled trial. Lancet. 2018;**391**(10115):31-40

[7] Thuesen AL, Riber LP, Veien KT, et al. Fractional flow reserve versus angiographically-guided coronary artery bypass grafting. Journal of the American College of Cardiology.

[5] Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. The New England Journal of Medicine.

[3] Park SJ, Ahn JM, Kim YH, et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. The New England Journal of Medicine.

[4] van Nunen LX, Zimmermann FM, Tonino PA, et al. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet.

[2] Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. The New England Journal of Medicine.

*Current Status, Perspectives, and Future Directions of Multivessel Disease and Left Main… DOI: http://dx.doi.org/10.5772/intechopen.89419*
